| Survival signaling by Notch1: mammalian target of rapamycin (mTOR)–dependent inhibition of p53 SK Mungamuri, XH Yang, AD Thor, K Somasundaram Cancer research 66 (9), 4715-4724, 2006 | 329 | 2006 |
| FOXO1 is an essential regulator of pluripotency in human embryonic stem cells X Zhang, S Yalcin, DF Lee, TYJ Yeh, SM Lee, J Su, SK Mungamuri, ... Nature cell biology 13 (9), 1092-1099, 2011 | 294 | 2011 |
| Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells S Yalcin, X Zhang, JP Luciano, SK Mungamuri, D Marinkovic, C Vercherat, ... Journal of Biological Chemistry 283 (37), 25692-25705, 2008 | 274 | 2008 |
| Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses S Das, E Sarrou, S Podgrabinska, M Cassella, SK Mungamuri, N Feirt, ... Journal of Experimental Medicine 210 (8), 1509-1528, 2013 | 190 | 2013 |
| Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity HM Chen, W van der Touw, YS Wang, K Kang, S Mai, J Zhang, ... The Journal of clinical investigation 128 (12), 5647-5662, 2018 | 164 | 2018 |
| ROS‐mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice S Yalcin, D Marinkovic, SK Mungamuri, X Zhang, W Tong, R Sellers, ... The EMBO journal 29 (24), 4118-4131, 2010 | 161 | 2010 |
| p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes EK Benson, SK Mungamuri, O Attie, M Kracikova, R Sachidanandam, ... Oncogene 33 (30), 3959-3969, 2014 | 132 | 2014 |
| p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus C Muñoz-Fontela, M Pazos, I Delgado, W Murk, SK Mungamuri, SW Lee, ... The Journal of Immunology 187 (12), 6428-6436, 2011 | 101 | 2011 |
| β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors L Grumolato, G Liu, T Haremaki, SK Mungamuri, P Mong, G Akiri, ... PLoS genetics 9 (8), e1003603, 2013 | 98 | 2013 |
| FOXO3‐mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis X Zhang, G Campreciós, P Rimmelé, R Liang, S Yalcin, SK Mungamuri, ... American journal of hematology 89 (10), 954-963, 2014 | 94 | 2014 |
| The C terminus of p53 regulates gene expression by multiple mechanisms in a target-and tissue-specific manner in vivo PJ Hamard, N Barthelery, B Hogstad, SK Mungamuri, CA Tonnessen, ... Genes & development 27 (17), 1868-1885, 2013 | 86 | 2013 |
| CRISPR-barcoding for intratumor genetic heterogeneity modeling and functional analysis of oncogenic driver mutations A Guernet, SK Mungamuri, D Cartier, R Sachidanandam, A Jayaprakash, ... Molecular cell 63 (3), 526-538, 2016 | 68 | 2016 |
| p53-mediated heterochromatin reorganization regulates its cell fate decisions SK Mungamuri, EK Benson, S Wang, W Gu, SW Lee, SA Aaronson Nature structural & molecular biology 19 (5), 478-484, 2012 | 61 | 2012 |
| USP7 enforces heterochromatinization of p53 target promoters by protecting SUV39H1 from MDM2-mediated degradation SK Mungamuri, RF Qiao, S Yao, JJ Manfredi, W Gu, SA Aaronson Cell reports 14 (11), 2528-2537, 2016 | 57 | 2016 |
| Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy R Nishad, D Mukhi, SV Tahaseen, SK Mungamuri, AK Pasupulati Journal of Biological Chemistry 294 (44), 16109-16122, 2019 | 50 | 2019 |
| Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component … A Troilo, EK Benson, D Esposito, RAA Garibsingh, EP Reddy, ... Oncotarget 7 (20), 28765, 2016 | 48 | 2016 |
| Chromatin modifications sequentially enhance ErbB2 expression in ErbB2-positive breast cancers SK Mungamuri, W Murk, L Grumolato, E Bernstein, SA Aaronson Cell reports 5 (2), 302-313, 2013 | 47 | 2013 |
| Nanomaterials multifunctional behavior for enlightened cancer therapeutics GSR Raju, B Dariya, SK Mungamuri, G Chalikonda, SM Kang, IN Khan, ... Seminars in cancer biology 69, 178-189, 2021 | 34 | 2021 |
| Hypoxia induces ZEB2 in podocytes: Implications in the pathogenesis of proteinuria K Nakuluri, D Mukhi, R Nishad, MA Saleem, SK Mungamuri, RK Menon, ... Journal of cellular physiology 234 (5), 6503-6518, 2019 | 34 | 2019 |
| Stabilization of hypoxia‐inducible factor 1α by cobalt chloride impairs podocyte morphology and slit‐diaphragm function K Nakuluri, D Mukhi, SK Mungamuri, AK Pasupulati Journal of cellular biochemistry 120 (5), 7667-7678, 2019 | 30 | 2019 |
Saghi GhaffariProfessor of CDRB and Oncological Sciences, Icahn School of Medicine at Mount SinaiBestätigte E-Mail-Adresse bei mssm.edu
